Motion Mapping in Humans as a Biomarker for Psychiatric Disorders

Neuropsychopharmacology - United Kingdom
doi 10.1038/s41386-018-0205-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clara Cell Protein as a Biomarker for Ozone-Induced Lung Injury in Humans

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2003English

Computing Corpus Callosum as Biomarker for Degenerative Disorders

2015English

The Potential of Oxytocin as a Therapeutic Target for Psychiatric Disorders

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2016English

Classifying Psychiatric Disorders as Communicable Diseases

The Lancet Psychiatry
PsychiatryBiological PsychiatryMental Health
2019English

Leptin: A Biomarker for Sleep Disorders?

Sleep Medicine Reviews
PulmonaryNeurologyRespiratory MedicinePhysiology
2014English

Classifying Psychiatric Disorders as Communicable Diseases

The Lancet Psychiatry
PsychiatryBiological PsychiatryMental Health
2019English

Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2017English

Peripheral Biomarker for Vascular Disorders

Biomarker Insights
BiochemistryMolecular MedicinePharmacology
2018English

Classifying Psychiatric Disorders as Communicable Diseases – Authors' Reply

The Lancet Psychiatry
PsychiatryBiological PsychiatryMental Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy